Dr. Sherita Hill Golden is the Hugh P. McCormick Family Professor of Endocrinology and Metabolism at Johns Hopkins University School of Medicine. She holds joint appointments in the Welch Center for Prevention, Epidemiology, and Clinical Research, in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and in the Armstrong Institute for Patient Safety and Quality. Dr. Golden graduated summa cum laude from the University of Maryland, College Park and Alpha Omega Alpha from the University of Virginia School of Medicine before training in Internal Medicine and Endocrinology, Diabetes, and Metabolism at the Johns Hopkins Hospital. During her endocrinology fellowship she received a Master of Health Science degree in Clinical Epidemiology from the Johns Hopkins University Bloomberg School of Public Health.
An internationally recognized physician-scientist and member of the National Academy of Medicine, the Association of American Physicians, and the American Society of Clinical Investigation, Dr. Golden is a board-certified, clinical endocrinologist cross trained as a diabetes and cardiovascular disease (CVD) epidemiologist. Her epidemiological research interests focus on two areas: (1) endogenous adrenal hormones as risk factors for CVD, type 2 diabetes, and insulin resistance and (2) mental health complications of diabetes and the biological, hormonal, and behavioral factors that might explain these associations. Her early research applied the tools of observational epidemiology to identify important endocrine risk factors—cortisol and endogenous sex hormones—associated with adverse metabolic outcomes. Her subsequent original data collection and analyses have helped define the impacts of cortisol and sex steroids on clinical expression and consequences of diabetes and CVD, allowing her to carve out a unique investigative niche integrating the tools of the molecular aspects of endocrinology with population science. Dr. Golden’s health services research focuses on understanding and eliminating diabetes health disparities and implementing and evaluating systems interventions to improve patient safety and quality of care in hospitalized patients with diabetes. She serves as the Principal Investigator of the Johns Hopkins site of the Diabetes Prevention Program Outcome Study and from 2003-2018, served as Director of the Inpatient Glucose Management Program for Johns Hopkins Hospital. Dr. Golden has used her executive leadership roles to develop systems, community, and policy interventions to improve the care of people with diabetes and promote health equity. She is the recipient of numerous awards recognizing her clinical, research, and leadership contributions.
Dr. Golden has been a dedicated member of The Endocrine Society since her first year of endocrinology fellowship, when she was appointed as one of fifteen inaugural fellows and students to The Endocrine Society Associates’ Council in 1998. She has previously served on the Membership Committee, Committee for Opportunity and Reaching Excellence, and the Editorial Board for the Journal of Clinical Endocrinology and Metabolism. Dr. Golden was the Writing Group Chairperson of the Endocrine Society’s first Scientific Statement on Health Disparities in Endocrine Disorders in 2012 and served as Writing Group Co-Chair for the updated scientific statement published in 2023. She is a mentor and faculty member for the Society’s FLARE and ExCEL programs. In the past, she also served on the National Board of Directors for the American Diabetes Association, including the Board’s Finance Committee, and was an Associate Editor for Diabetes Care.
